AstraZeneca, Mayo Clinic, Virginia Polytechnic Institute and State University deal

The university and the clinic granted AstraZeneca exclusive, worldwide rights to develop and commercialize a portfolio of preclinical small molecule triple reuptake inhibitors (TRI) that inhibit the n...